Company Filing History:
Years Active: 2021-2025
Title: Scott Kopetz: Innovator in Cancer Biomarkers
Introduction
Scott Kopetz is a prominent inventor based in Austin, TX, known for his significant contributions to cancer research. He holds two patents that focus on gene mutations and copy number alterations in key oncogenes. His work aims to improve the diagnosis and treatment of cancer, particularly in relation to resistance to anti-EGFR therapies.
Latest Patents
Kopetz's latest patents involve the identification of sequence variants and copy number variations in the EGFR, KRAS, and MET genes. These biomarkers are crucial for understanding resistance to anti-EGFR therapies in cancer patients. The patents provide methods for detecting these biomarkers, which can enhance diagnostic accuracy and treatment strategies for cancer.
Career Highlights
Throughout his career, Scott Kopetz has worked with notable organizations, including Guardant Health, Inc. and the University of Texas System. His experience in these institutions has allowed him to advance his research and contribute to the field of oncology significantly.
Collaborations
Some of his notable coworkers include Amirali Talasaz and AmirAli Talasaz, who have collaborated with him on various projects related to cancer research and biomarker development.
Conclusion
Scott Kopetz is a key figure in the field of cancer research, with his patents paving the way for advancements in the diagnosis and treatment of cancer. His work continues to impact the medical community and improve patient outcomes.